After Skin Cancer: Your Follow-Up Schedule and What to Watch For

Why Follow-Up Matters After Skin Cancer Treatment

When skin cancer treatment is complete and the wound is healing, it is natural to want to put the experience behind you. But finishing treatment is not the end of the story. It is the beginning of a new phase: structured surveillance.

There are two distinct risks that follow-up visits address. The first is local recurrence, where cancer regrows at or near the original treatment site. With Mohs surgery, this risk is very low - around 1% for basal cell carcinoma (BCC) and 3% for squamous cell carcinoma (SCC). The second risk is the development of entirely new skin cancers at different locations on your body. This second risk is the more common concern and the primary reason follow-up matters so much.

Patients who have had one skin cancer carry a significantly elevated risk of developing another. Studies consistently show that 30 to 50 percent of patients treated for BCC will develop a second, unrelated BCC within five years. For SCC, the risk of a new primary tumor is similarly elevated. And for melanoma survivors, the lifetime risk of a second melanoma is roughly 18 times that of the general population.

Follow-up visits catch these new cancers early, when they are small, superficial, and most treatable. A recurrence or new tumor detected at a routine follow-up visit is a far simpler problem than one that grows unnoticed for months or years.

“Treatment removes the cancer, but follow-up protects your future. In Israel, where UV exposure is relentless and the risk of new skin cancers is high, a structured surveillance plan is not a suggestion - it is a medical necessity.”

Follow-Up Schedules by Cancer Type

The recommended frequency of follow-up visits depends on the type of skin cancer you were treated for, the stage at diagnosis, and your individual risk profile. The schedules below reflect current guidelines from the NCCN and European dermatological societies, adapted for clinical practice in Israel.

Basal Cell Carcinoma (BCC)

BCC is the least aggressive of the three major skin cancers and has an extremely low risk of spreading to other organs. However, the risk of developing additional BCCs is substantial.

The focus during BCC follow-up is on examining the treatment site for recurrence, performing a full-body skin check for new BCCs or other skin cancers, and evaluating any new or changing lesions.

Squamous Cell Carcinoma (SCC)

SCC carries a higher risk than BCC of local recurrence, regional spread to lymph nodes, and in rare cases, distant metastasis. The follow-up schedule is therefore more intensive.

For high-risk SCC, follow-up visits may include lymph node palpation and, in select cases, imaging studies to monitor for regional spread.

Melanoma

Melanoma requires the most intensive and prolonged surveillance of all skin cancers. Even thin melanomas (Breslow thickness under 1 mm) carry a meaningful risk of recurrence years or even decades after treatment.

Melanoma follow-up may include blood tests (LDH levels), imaging (CT, PET-CT, or ultrasound of regional lymph nodes), and close monitoring of any atypical moles that could represent new primary melanomas.

What Happens During a Follow-Up Visit

A thorough follow-up visit is more than a quick look at your scar. It is a systematic evaluation that covers several components.

Scar and Treatment Site Inspection

The dermatologist examines the surgical scar and the tissue immediately surrounding it for any signs of tumor regrowth. For BCC, this might appear as a new pearly bump, a small area of crusting, or a change in the scar's texture. For SCC, recurrence may present as a firm nodule, a non-healing sore, or a rough, scaly area within or adjacent to the scar. For melanoma, recurrence can appear as a pigmented spot within the scar or as small satellite nodules nearby.

Full-Body Skin Examination

Every follow-up visit includes a complete skin examination from head to toe. This is when new, unrelated skin cancers are most often detected. The dermatologist systematically evaluates the scalp, face, ears, neck, trunk, arms, hands, legs, feet, and nails.

Dermoscopy

A dermatoscope - a handheld magnifying instrument with polarized light - is used to examine any suspicious or changing lesions at 10x magnification. Dermoscopy reveals subsurface structures invisible to the naked eye, such as vascular patterns, pigment distribution, and architectural changes that indicate early malignancy. In our clinic, digital dermoscopy allows images to be stored and compared over time, making it possible to detect subtle changes that might otherwise go unnoticed.

Lymph Node Examination

For SCC and melanoma patients, the dermatologist palpates the regional lymph nodes to check for enlargement. For melanoma patients who underwent sentinel lymph node biopsy, the draining lymph node basins are examined with particular attention. Any new, firm, or growing lymph nodes warrant further evaluation, typically with ultrasound.

Discussion and Planning

Each visit includes a conversation about any changes you have noticed, a review of your sun protection habits, and planning for the next appointment. This is your opportunity to point out any spots that concern you, even if they seem minor.

Monthly Self-Examination: Your Role Between Visits

Professional follow-up visits are essential, but they happen a few times per year at most. Between appointments, you are the primary observer of your own skin. A monthly self-examination takes only 5 to 10 minutes and significantly increases the chances of catching a problem early.

The basics of self-examination involve standing in front of a full-length mirror in a well-lit room and systematically checking every area of skin on your body. Use a hand mirror for your back, scalp, and other hard-to-see areas. Ask a partner to help examine areas you cannot see well yourself. Pay special attention to your treatment scar and the surrounding skin.

What you are looking for is anything new, changing, or unusual: a spot that was not there before, a mole that has changed shape or color, a sore that does not heal, or any area that bleeds, itches, or crusts repeatedly. If you notice something concerning, do not wait for your next scheduled appointment - contact your dermatologist right away.

Signs of Recurrence to Watch For

Knowing the specific warning signs of recurrence helps you monitor your skin effectively.

BCC Recurrence Signs

- A pearly or translucent bump appearing within or near the scar - A flat, scar-like area that was not present before or that appears to be expanding - A small area of bleeding, crusting, or ulceration at the treatment site - A pinkish, shiny patch developing near the original surgery location

SCC Recurrence Signs

- A firm, raised nodule at or near the treatment site - A rough, scaly, or crusted area that persists despite treatment - A sore that repeatedly opens, bleeds, and fails to heal - Pain, numbness, or tingling near the scar, which may suggest perineural involvement

Melanoma Recurrence Signs

- A new pigmented spot within or immediately adjacent to the scar - Small, dark satellite nodules appearing near the original site - A palpable lump in the nearby lymph node region - Systemic symptoms such as unexplained fatigue, weight loss, or new lumps under the skin (for advanced recurrence)

Most recurrences are detected within the first two years after treatment. After five years, the risk decreases substantially but never reaches zero, which is why long-term surveillance remains important.

The Risk of New Skin Cancers

Beyond recurrence of the original tumor, patients treated for skin cancer face a meaningfully higher risk of developing entirely new primary skin cancers. This is one of the most important messages in post-treatment counseling.

The numbers are clear: patients treated for one BCC have a 30 to 50 percent probability of developing a new BCC within five years. Patients who have had multiple BCCs face an even higher risk. For SCC, the risk of a new primary SCC after a first diagnosis is approximately 18 percent within three years. And melanoma patients carry a 2 to 10 percent risk of developing a second primary melanoma, with that risk persisting for decades.

These statistics are not meant to cause anxiety. They are meant to reinforce why follow-up visits are not optional. The same genetic factors, cumulative UV damage, and skin type that produced the first cancer continue to drive risk going forward.

Sun Protection as an Ongoing Strategy

After skin cancer treatment, sun protection is not a temporary measure - it is a permanent change in how you interact with UV radiation.

In Israel, where the UV index regularly reaches extreme levels during summer and remains moderate even in winter, consistent daily sun protection is especially important. The core practices include applying broad-spectrum SPF 30 or higher sunscreen every morning, wearing a wide-brimmed hat and UPF-rated clothing when outdoors, seeking shade during peak UV hours (approximately 10:00 AM to 4:00 PM), and protecting your surgical scar from direct sun exposure for at least 12 months after treatment.

Sun protection does not mean avoiding the outdoors. Israel's outdoor lifestyle is a source of physical and mental well-being. The goal is to enjoy it safely, with the understanding that each unprotected exposure adds to the cumulative UV damage that drives skin cancer risk.

The Emotional Side of Surveillance

The anxiety that accompanies follow-up visits is real and common. Research on fear of cancer recurrence shows that many skin cancer survivors experience elevated anxiety before and during surveillance appointments. Some patients describe a cycle of worry in the weeks leading up to each visit, followed by relief when results are clear, followed by the gradual return of worry as the next visit approaches.

This experience is normal. Acknowledging it is the first step toward managing it. Several strategies can help.

First, understand that following a structured schedule actually reduces anxiety over time. Knowing that your skin is being professionally monitored at regular intervals provides a framework that replaces uncertainty with a concrete plan. Second, channel vigilance into action by performing your monthly self-exams consistently. Taking an active role in your own surveillance provides a sense of control. Third, talk about it. Discuss your concerns with your dermatologist, your family, or a mental health professional if the anxiety becomes difficult to manage. You are not alone in feeling this way.

The goal of surveillance is not to live in fear. It is to live with confidence, knowing that you and your medical team are watching carefully and that any new issue will be caught early.

Frequently Asked Questions

How long do I need follow-up after skin cancer?

The duration depends on the type of cancer. For BCC, structured follow-up is recommended for at least 5 years, followed by annual skin checks for life. For SCC, a minimum of 5 years of structured surveillance is standard. For melanoma, most guidelines recommend at least 10 years of structured follow-up, and many dermatologists advocate for lifelong annual exams. Because the risk of new skin cancers persists indefinitely, annual skin screenings are advisable for all skin cancer survivors regardless of cancer type.

What if I miss a follow-up appointment?

Reschedule as soon as possible. One missed appointment is unlikely to change your outcome, but a pattern of skipped visits increases the risk that a recurrence or new cancer goes undetected. If it has been more than a year since your last skin check, call your dermatologist promptly to get back on schedule.

Can I do my follow-up with my family doctor instead of a dermatologist?

Family physicians can perform general skin checks, but dermatologists have specialized training and tools - particularly dermoscopy - that significantly improve the detection of subtle or early-stage skin cancers. For patients with a history of skin cancer, follow-up with a dermatologist is strongly recommended. In Israel, referrals to dermatology through your kupat cholim (health fund) are straightforward.

Will my follow-up schedule change over time?

Yes. Follow-up intervals typically become less frequent as time passes without recurrence or new tumors. However, if you develop additional skin cancers or pre-cancerous lesions during surveillance, your schedule may be intensified. Your dermatologist adjusts the plan based on your ongoing risk profile.

Does sunscreen really prevent new skin cancers, or is the damage already done?

Both past and ongoing UV exposure contribute to skin cancer risk. While you cannot undo cumulative damage from decades of sun exposure, consistent sunscreen use has been shown to reduce the development of new skin cancers. A landmark Australian randomized trial demonstrated a 40 percent reduction in new SCC among participants who applied sunscreen daily compared to those who used it at their discretion. The damage is not all "already done" - protection today genuinely reduces tomorrow's risk.

I feel a lump near my scar. Should I be worried?

Not necessarily, but it should always be evaluated. Scar tissue can feel firm or lumpy as it matures, and small cysts or other benign changes can develop near surgical sites. However, any new or growing lump near a skin cancer treatment site requires examination by your dermatologist to rule out recurrence. Do not wait for your next scheduled appointment - call and describe what you are feeling.